Cost-effectiveness of everolimus plus exemestane in post-menopausal hormone receptor positive metastatic breast cancer.
Simon B. Zeichner
No relevant relationships to disclose
Kiran Kumar Venkata Raja Avancha
No relevant relationships to disclose
Gilberto Lopes
Honoraria - Novartis; Pfizer
Research Funding - Novartis; Pfizer
Stefan Gluck
No relevant relationships to disclose
Alberto J. Montero
No relevant relationships to disclose